局部区域复发脊索瘤管理的最佳实践:脊索瘤全球共识组立场文件
脊索瘤是颅底和中轴骨的罕见恶性肿瘤,既往缺乏专家共识导致诊疗不一致。欧洲肿瘤内科学会(ESMO)与脊索瘤基金会召集多学科专家组,于2015年11月召开第二次共识会议,针对局部复发脊索瘤制定循证最佳实践推荐,本文即该共识成果,补充首份立场文件。
要点
- 脊索瘤为颅底和中轴骨的罕见恶性肿瘤,既往缺乏专家共识致诊疗不一致。
- ESMO与脊索瘤基金会召集多学科专家组,以共识方式制定脊索瘤最佳实践。
- 本文聚焦局部复发脊索瘤的治疗推荐,补充首份立场文件。
核心结论
- 该共识明确了局部区域复发脊索瘤管理的最佳实践推荐,补充首份立场文件的推荐。
研究设计与样本
- 由欧洲肿瘤内科学会(ESMO)与脊索瘤基金会召集的多学科共识专家组立场文件。
- 2015年11月召开第二次共识会议,参会专家超过60名,来自欧洲、美国与日本。
主要发现
- 首份推荐于2015年1月发表,覆盖原发与转移性脊索瘤的管理。
- 局部区域失败的管理需额外证据与进一步讨论,故召开第二次共识会议。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chordomas are rare, malignant bone tumors of the skull-base and axial skeleton. Until recently, there was no consensus among experts regarding appropriate clinical management of chordoma, resulting in inconsistent care and suboptimal outcomes for many patients. To address this shortcoming, the European Society of Medical Oncology (ESMO) and the Chordoma Foundation, the global chordoma patient advocacy group, convened a multi-disciplinary group of chordoma specialists to define by consensus evidence-based best practices for the optimal approach to chordoma. In January 2015, the first recommendations of this group were published, covering the management of primary and metastatic chordomas. Additional evidence and further discussion were needed to develop recommendations about the management of local-regional failures. Thus, ESMO and CF convened a second consensus group meeting in November 2015 to address the treatment of locally relapsed chordoma. This meeting involved over 60 specialists from Europe, the United States and Japan with expertise in treatment of patients with chordoma. The consensus achieved during that meeting is the subject of the present publication and complements the recommendations of the first position paper.
引用
- Stacchiotti S, Gronchi A, Fossati P, et al. Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group. Ann Oncol. 2017. PMID: 28184416. doi:10.1093/annonc/mdx054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。